Search

Author/Creator Cheinquer, Nelson

1. Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment. Issue 9 (2nd March 2022)

Authors:
Sulkowski, Mark; Telep, Laura E.; Colombo, Massimo; Durand, Francois; Reddy, K. Rajender; Lawitz, Eric; Bourlière, Marc; Cheinquer, Nelson; Scherbakovsky, Stacey; Ni, Liyun; Force, Lindsey; Ramroth, Heribert; Gaggar, Anuj; Chokkalingam, Anand P.; Sise, Meghan E.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 55:Issue 9(2022)
Page Start:
1169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. (April 2022)

Authors:
Solomon, Sunil S; Wagner-Cardoso, Sandra; Smeaton, Laura; Sowah, Leonard A; Wimbish, Chanelle; Robbins, Gregory; Brates, Irena; Scello, Christine; Son, Annie; Avihingsanon, Anchalee; Linas, Benjamin; Anthony, Donald; Nunes, Estevão Portela; Kliemann, Dimas A; Supparatpinyo, Khuanchai; Kityo, Ciss...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 4(2022)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗